AML patients showed a lower percentage of NK cells defined as CD3− CD56+ lymphocytes (mean ± SD; 11.02 ± 12.22) than healthy donors (19.82 ± 14.71). The gene discussed is NCAM1; the disease is acute myeloid leukemia.